Achieve Life Sciences (ACHV) Receivables - Accured (2011 - 2016)
Achieve Life Sciences' Receivables - Accured was $32,000 in Q4 2016, down 71.2% from $111,000 a year earlier and down 11.1% from the prior quarter.
Powered by 
Analysis
Achieve Life Sciences (ACHV) Receivables - Accured (2011 - 2016) Analysis & Trends
From Q4 2011 onward, Achieve Life Sciences has reported Receivables - Accured for 17 quarters.
- Receivables - Accured has now declined for five consecutive years, with a five-year compound annual growth rate of -38.5% (FY2011 to FY2016).
- In earlier years, Receivables - Accured was $111,000 in FY2015 (-1.8%), $113,000 in FY2014 (-48.2%), $218,000 in FY2013 (-33.3%) and $327,000 in FY2012 (-9.9%).
- The Q4 2016 figure marks the lowest quarterly Receivables - Accured since Q3 2014.
- Compared with a year earlier, Receivables - Accured has declined for five straight quarters, with an average decline of 9.4% over the last seven quarters.
- The best year-over-year quarter for Receivables - Accured over five years was Q3 2015 (growth of 152.6%); the worst was Q3 2014 (a decline of 93.6%).
- Per Business Quant data, ACHV's Receivables - Accured in the three quarters before Q4 2016 was $36,000 (Q3 2016), $47,000 (Q2 2016) and $53,000 (Q1 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Achieve Life Sciences | 337.86 Mn | 337.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 32,000.00 |
| Sep 30, 2016 | 36,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Dec 31, 2015 | 111,000.00 |
| Sep 30, 2015 | 48,000.00 |
| Jun 30, 2015 | 76,000.00 |
| Mar 31, 2015 | 71,000.00 |
| Dec 31, 2014 | 113,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 166,000.00 |
| Dec 31, 2013 | 218,000.00 |
| Sep 30, 2013 | 295,000.00 |
| Jun 30, 2013 | 300,000.00 |
| Mar 31, 2013 | 321,000.00 |
| Dec 31, 2012 | 327,000.00 |
| Dec 31, 2011 | 363,000.00 |
API Access
Achieve Life Sciences Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=ACHV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "ACHV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=ACHV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();